Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

Abstract

ONJ has been increasingly suspected to be a potential complication of bisphosphonate therapy in recent years. Thus, the ASBMR leadership appointed a multidisciplinary task force to address key questions related to case definition, epidemiology, risk factors, diagnostic imaging, clinical management, and future areas for research related to the disorder. This report summarizes the findings and recommendations of the task force. Introduction: The increasing recognition that use of bisphosphonates may be associated with osteonecrosis of the jaw (ONJ) led the leadership of the American Society for Bone and Mineral Research (ASBMR) to appoint a task force to address a number of key questions related to this disorder. Materials and Methods: A multidisciplinary expert group reviewed all pertinent published data on bisphosphonate-associated ONJ. Food and Drug Administration drug adverse event reports were also reviewed. Results and Conclusions: A case definition was developed so that subsequent studies could report on the same condition. The task force defined ONJ as the presence of exposed bone in the maxillofacial region that did not heal within 8 wk after identification by a health care provider. Based on review of both published and unpublished data, the risk of ONJ associated with oral bisphosphonate therapy for osteoporosis seems to be low, estimated between 1 in 10,000 and <1 in 100,000 patient-treatment years. However, the task force recognized that information on incidence of ONJ is rapidly evolving and that the true incidence may be higher. The risk of ONJ in patients with cancer treated with high doses of intravenous bisphosphonates is clearly higher, in the range of 1–10 per 100 patients (depending on duration of therapy). In the future, improved diagnostic imaging modalities, such as optical coherence tomography or MRI combined with contrast agents and the manipulation of image planes, may identify patients at preclinical or early stages of the disease. Management is largely supportive. A research agenda aimed at filling the considerable gaps in knowledge regarding this disorder was also outlined.

Overview

Integrity signals

Registry

Crossref · 10.1359/jbmr.0707onj

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Research works printed but not linked: 3

  1. Felsenberg, 2006, Bisphosphonattherapie assoziierte, Kiefernekrosen Deutsches Arzteblatt, 46, A3078
  2. Van Poznak, 2004, Osteonecrosis of the maxilla and mandible in patients with metastatic breast cancer, J Bone Miner Res, 19, S227
  3. Ruggiero, 2004, Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004 · DOI · Paper page

Cited by

See all 1,650

Metadata

Authors
Khosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., McCauley, L. K., McGowan, J., McKee, M. D., Mohla, S., Pendrys, D. G., Raisz, L. G., Ruggiero, S. L., Shafer, D. M., Shum, L., Silverman, S. L., Van Poznak, C. H., Watts, N., Woo, S.-B., & Shane, E.
Affiliations
  • American Society for Bone and Mineral Research (US)
  • ASBMR Task Force on Bisphosphonate-Associated ONJ
Corresponding author
Shane, Elizabeth
Venue
Journal of Bone and Mineral Research
Published
2007-10-01
Volume
22
Issue
10
Pages
1479-1491
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2150904792
Cited by
1,650
References
43
Citations by year
2026: 20 · 2025: 40 · 2024: 41 · 2023: 35 · 2022: 52 · 2021: 45 · 2020: 71 · 2019: 58 · 2018: 58 · 2017: 70 · 2016: 89 · 2015: 114 · 2014: 121 · 2013: 152 · 2012: 118
FWCI
69.84
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Bone and Mineral Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Procter and Gamble
  • American Society for Bone and Mineral Research
Topics
  • Health Sciences › Medicine › Oncology › Bone health and treatments
  • Health Sciences › Dentistry › General Dentistry › Oral health in cancer treatment
  • Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
Keywords
bisphosphonate-related osteonecrosis of the jaw, bisphosphonates, osteonecrosis of the jaw, case definition, risk factors, oral bisphosphonates, osteoporosis, cancer patients, intravenous bisphosphonates, diagnostic imaging, optical coherence tomography, magnetic resonance imaging, clinical management, drug adverse events
MeSH terms
Adult, Aged, Aged, 80 and over, Americas, Animals, Diagnosis, Differential, Diphosphonates, Female, Humans, Jaw Diseases, Male, Middle Aged, Minerals, Osteonecrosis, Risk Factors, Societies, Medical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research. https://app.cochat.ai/papers/10.1359/jbmr.0707onj
The paper
Khosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., McCauley, L. K., McGowan, J., McKee, M. D., Mohla, S., Pendrys, D. G., Raisz, L. G., Ruggiero, S. L., Shafer, D. M., Shum, L., . . . Shane, E. (2007). Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.0707onj

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.